KAT2B and non-small cell lung carcinoma: Recent study has demonstrated that KAT2B expression positively correlated with the outcomes of patients with lung adenocarcinoma. Additionally, KAT2B was synergistic with multiple immune cell infiltration and immune checkpoints in NSCLC [118].